Paper23905680
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.
Yu CW and 3 others. J Med Chem, 2013. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease. Papers, record 23905680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23905680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histone Deacetylase Inhibitors | Major topic |
| Histone Deacetylases | Major topic |
| Quinazolinones | Major topic |
| Animals | |
| Histone Deacetylase 6 | |
| Humans | |
| Magnetic Resonance Spectroscopy | |
| PC12 Cells | |
| Rats | |
| Spectrometry, Mass, Electrospray Ionization |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42395723 | A chemoenzymatic synthesis of amide-containing quinazolin-4(3H)-one derivatives. | RSC Adv | 2026 | https://conductscience.org/library/papers/42395723 | PubMed |
| 41940800 | GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. | J Med Chem | 2026 | https://conductscience.org/library/papers/41940800 | PubMed |
| 40530721 | Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future Perspectives. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/40530721 | PubMed |
| 39219429 | Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease. | Mini Rev Med Chem | 2025 | https://conductscience.org/library/papers/39219429 | PubMed |
| 38859778 | Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents. | Mini Rev Med Chem | 2024 | https://conductscience.org/library/papers/38859778 | PubMed |
| 37190931 | Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/37190931 | PubMed |
| 36036883 | HDAC6: A unique HDAC family member as a cancer target. | Cell Oncol (Dordr) | 2022 | https://conductscience.org/library/papers/36036883 | PubMed |
| 35424458 | Metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates at room temperature. | RSC Adv | 2021 | https://conductscience.org/library/papers/35424458 | PubMed |
| 35408604 | Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety. | Molecules | 2022 | https://conductscience.org/library/papers/35408604 | PubMed |
| 32565717 | Methods for Hydroxamic Acid Synthesis. | Curr Org Chem | 2019 | https://conductscience.org/library/papers/32565717 | PubMed |
| 32013157 | HDAC6-an Emerging Target Against Chronic Myeloid Leukemia? | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32013157 | PubMed |
| 32012896 | The Effect of Protein-Rich Extract from Bombyx Batryticatus against Glutamate-Damaged PC12 Cells Via Regulating γ-Aminobutyric Acid Signaling Pathway. | Molecules | 2020 | https://conductscience.org/library/papers/32012896 | PubMed |
| 31788622 | Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors. | ACS Omega | 2019 | https://conductscience.org/library/papers/31788622 | PubMed |
| 30645113 | Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors. | J Med Chem | 2019 | https://conductscience.org/library/papers/30645113 | PubMed |
| 30557385 | Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors. | PLoS One | 2018 | https://conductscience.org/library/papers/30557385 | PubMed |
| 30511829 | Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/30511829 | PubMed |
| 30332838 | Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30332838 | PubMed |
| 30261020 | Novel histone deacetylase inhibitors and embryo aggregation enhance cloned embryo development and ES cell derivation in pigs. | PLoS One | 2018 | https://conductscience.org/library/papers/30261020 | PubMed |
| 29869029 | Dynamic localization of α-tubulin acetyltransferase ATAT1 through the cell cycle in human fibroblastic KD cells. | Med Mol Morphol | 2018 | https://conductscience.org/library/papers/29869029 | PubMed |
| 29844403 | The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29844403 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| HDAC6 | 10013 | PubTator's text mining | https://conductscience.org/library/genes/10013 | NCBI Gene |
| HDAC9 | 9734 | PubTator's text mining | https://conductscience.org/library/genes/9734 | NCBI Gene |
| TUBA1B | 10376 | PubTator's text mining | https://conductscience.org/library/genes/10376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23905680
GET https://conductscience.org/api/papers/v1/23905680/cited_by?page=2